If not administered properly, health experts say medications like Ozempic, Mounjaro, and Wegovy can cause gastrointestinal ...

Over 40% of U.S. adults meet the medical classification for obesity, according to the Centers for Disease Control and ...

Not all weight loss programs are made equal—to reach a healthy, sustainable weight, personalized programs offer the best ...

It’s possible that GLP-1s may be useful for a range of substance use disorders, including opioid use disorder and nicotine ...

As demand remains high for GLP-1 drugs, primary care physicians are concerned about the risks of patients using third-party ...

Weight-inclusive health care is the provision of equitable care without perpetuating weight stigma among patients of all body ...

Independence Blue Cross began limiting coverage of GLP-1 drugs on Jan. 1 to some medical conditions, but not obesity or weight loss.

Liraglutide, a GLP-1 significantly lowers the rate of recurrent stroke in patients with diabetes, with no apparent increase ...

Weight loss drugs like Ozempic and Wegovy dominated 2024. Securing insurance to cover the costs is a different challenge ...

Zero Doubt Club, a Northeast Ohio-based wellness center, has introduced a GLP-1 weight-loss program that combines medical ...